Piramal Pharma completes acquisition of Hemmo Pharmaceuticals

Mumbai, Jun 23 (IANS): Piramal Pharma has completed the acquisition of Hemmo Pharmaceuticals Private Ltd for cash consideration of Rs 775 crore and earn-outs linked to achievement of milestones.

In March, Piramal Enterprises, the parent company of Piramal Pharma, had announced the proposed acquisition.

"We wish to inform you that PPL has completed the acquisition of Hemmo on 22nd June, 2021 and the transaction is now closed," Piramal Enterprises said in a regulatory filing on Wednesday.

The development marks Piramal Pharma's foray into manufacturing of peptide APIs (active pharmaceutical ingredients), complementing its existing offerings.

Hemmo is one of the few pure-play synthetic peptide API manufacturers in the global marketplace. With the addition of Hemmo's capabilities, PPS would gain access to the growing peptide API market and enhance its ability to offer integrated services to its customers globally.

Around 10.40 a.m., shares of Piramal Enterprises on the BSE were trading at Rs 2,454.90, higher by Rs 8.70 or 0.36 per cent from its previous close.


Top Stories

Leave a Comment

Title: Piramal Pharma completes acquisition of Hemmo Pharmaceuticals

You have 2000 characters left.


Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.

Security Validation

Enter the characters in the image